Vasopressin in rats with genetic and streptozocin-induced diabetes.
Rats were administered streptozocin (STZ; 50 or 75 mg/kg i.v., tail vein) or vehicle. Approximately 2 wk later, venous and arterial catheters was implanted for subsequent (24 h later) vasopressin, electrolyte, and hemodynamic measurements. STZ-induced diabetic (STZ-D) rats demonstrated a dose-dependent increase in the plasma glucose concentration, plasma osmolality, and plasma vasopressin concentration. Mean arterial blood pressure (MABP) was unchanged, but heart rate was reduced. Diabetes-prone BB rats, maintained on or withdrawn from insulin treatment for 24-48 h, and diabetes-resistant rats were instrumented and studied as above. Spontaneous-diabetes-prone rats demonstrated increase in plasma glucose concentration and plasma osmolality similar to STZ-D rats but had significantly greater plasma vasopressin concentrations. The significant decrease in MABP observed in these animals probably contributed to the enhanced vasopressin response. We conclude that both osmotic and cardiovascular parameters play important roles in vasopressin secretion in diabetic rats.
Brooks
D P
DP
Department of Physiology and Biophysics, University of Tennessee, Memphis.
Nutting
D F
DF
Crofton
J T
JT
Share
L
L
D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure; D003921:Diabetes Mellitus, Experimental / Q000097:blood* / Q000503:physiopathology; D008297:Male; D009994:Osmolar Concentration; D051381:Rats; D011919:Rats, Inbred Strains; D014667:Vasopressins / Q000097:blood*
D001786:Blood Glucose; D014667:Vasopressins